alpha-naphthoflavone has been researched along with bosentan anhydrous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endlich, K; Helwig, JJ; Muller, C | 1 |
1 other study(ies) available for alpha-naphthoflavone and bosentan anhydrous
| Article | Year |
|---|---|
AT2 antagonist-sensitive potentiation of angiotensin II-induced constriction by NO blockade and its dependence on endothelium and P450 eicosanoids in rat renal vasculature.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arachidonic Acid; Benzoflavones; Bosentan; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Endothelin Receptor Antagonists; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Kidney; Male; Nitric Oxide; Norepinephrine; Perfusion; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonamides; Vascular Resistance; Vasoconstriction | 1998 |